Moreover, their analysis found that almost half of tumor-infiltrating CD8+ T cells in SMA-560 were triply positive for the three aforementioned checkpoints, and the pattern of co-expression was similar to that observed in human GBM samples [51]. The gene discussed is CD8A; the disease is glioblastoma.